Skip to main content
. 2014 Nov 10;143(4):651–660. doi: 10.1111/imm.12346

Figure 9.

Figure 9

Histone H3 lysine methylation levels at the tumour necrosis factor-α (TNF-α) promoter of spleen with/without prenatal dexamethasone (DEX) treatment. Bar graphs showing the (a) H3K4me1, (b) H3K4me3 and (c) H3K36me3 levels of prenatal DEX group relative to vehicle at the TNF-α promoter. Chromatin immunoprecipitation assays were performed with H3K4me1, H3K4me3 and H3K36me3 antibodies. Results were expressed as fold difference over vehicle (mean ± SEM; *P < 0·05; n = 6).